Literature DB >> 32352187

Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma via Conventional and Contrast-Enhanced Ultrasound.

Lingling Tao1, Wei Zhou2, Weiwei Zhan2, Weiwei Li1, Yi Wang1, Jinfang Fan1.   

Abstract

OBJECTIVES: To investigate the independent risk factors for cervical lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC) and establish a prediction model via conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS).
METHODS: A total of 275 patients with single PTC, who were admitted to our hospital from January 2016 to December 2018, were enrolled in this study. The clinical characteristics and features of the tumor on conventional US and CEUS were retrospectively analyzed. A binary logistic regression model was established, and the diagnostic efficacy of conventional US and CEUS was compared.
RESULTS: The binary logistic regression analysis showed that age younger than 38 years, size of 10.0 mm or greater, solid composition, peak of the nodule interior of 28.3750 or greater, and area under the curve (AUC) of the peripheral ring of less than 3.2500 were independent risk factors of CLNM (P < .05, for all). Prediction model: Logit (p) = -4.135 + 1.040 (age) + 1.920 (size) + 1.769 (composition) + 1.230 (peak of nodule interior) + 0.812 (AUC of peripheral ring). The model positively predicted CLNM at a value of L > -0.199. The AUC, sensitivity, and negative predictive value of the receiver operating characteristic curve for the model were 0.727, 71.7%, and 75.2%, respectively, which were significantly higher than those of conventional US (Z = -2.403; P = .016; Z = -5.330; P < .001; and Z = -2.390; P = .017). The specificity of the model was 73.7%, which was lower than that of conventional US (Z = 3.508; P < .001).
CONCLUSIONS: The preoperative prediction model established via conventional US and CEUS may be helpful to evaluate CLNM in patients with PTC and determine the appropriate treatment options.
© 2020 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  cervical lymph node metastasis; contrast-enhanced ultrasound; conventional ultrasound; papillary thyroid carcinoma

Mesh:

Year:  2020        PMID: 32352187     DOI: 10.1002/jum.15315

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  9 in total

1.  Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.

Authors:  Yin-Zhu Zhao; Nian-An He; Xian-Jun Ye; Fu Jin; Meng-Xue Li; Xianxian Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  Value of Contrast-Enhanced Ultrasound in the Preoperative Evaluation of Papillary Thyroid Carcinoma Invasiveness.

Authors:  Lei Chen; Luzeng Chen; Zhenwei Liang; Yuhong Shao; Xiuming Sun; Jinghua Liu
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

3.  Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.

Authors:  Tian Xue; Chang Liu; Jing-Jing Liu; Yan-Hong Hao; Yan-Ping Shi; Xiu-Xiu Zhang; Yan-Jing Zhang; Yu-Fang Zhao; Li-Ping Liu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 4.  2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations.

Authors:  Eun Ju Ha; Sae Rom Chung; Dong Gyu Na; Hye Shin Ahn; Jin Chung; Ji Ye Lee; Jeong Seon Park; Roh-Eul Yoo; Jung Hwan Baek; Sun Mi Baek; Seong Whi Cho; Yoon Jung Choi; Soo Yeon Hahn; So Lyung Jung; Ji-Hoon Kim; Seul Kee Kim; Soo Jin Kim; Chang Yoon Lee; Ho Kyu Lee; Jeong Hyun Lee; Young Hen Lee; Hyun Kyung Lim; Jung Hee Shin; Jung Suk Sim; Jin Young Sung; Jung Hyun Yoon; Miyoung Choi
Journal:  Korean J Radiol       Date:  2021-10-26       Impact factor: 3.500

5.  Value of Contrast-Enhanced Ultrasound for Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Fengkai Fang; Yi Gong; Liyan Liao; Fei Ye; Zhongkun Zuo; Xiaodu Li; Qi Zhang; Kui Tang; Yan Xu; Rongsen Zhang; Sijie Chen; Chengcheng Niu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-03       Impact factor: 5.555

6.  Reassessing the Value of Contrast-Enhanced Ultrasonography in Differential Diagnosis of Cervical Tuberculous Lymphadenitis and Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Authors:  Xu Zhang; Lingling Wang; Na Feng; Tu Ni; Wei Tang
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

7.  Ultrasound and Contrast-Enhanced Ultrasound Characteristics Associated With cN1 and Microscopic pN1 in Papillary Thyroid Carcinoma.

Authors:  Wen Li; Shusheng Qiu; Ling Ren; Qiuyang Li; Shaowei Xue; Jie Li; Yan Zhang; Yukun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

8.  Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma.

Authors:  Fei Ye; Yi Gong; Kui Tang; Yan Xu; Rongsen Zhang; Sijie Chen; Xiaodu Li; Qi Zhang; Liyan Liao; Zhongkun Zuo; Chengcheng Niu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-05       Impact factor: 6.055

9.  Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.

Authors:  Peile Jin; Jifan Chen; Yiping Dong; Chengyue Zhang; Yajun Chen; Cong Zhang; Fuqiang Qiu; Chao Zhang; Pintong Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.